应用羟乙基淀粉130/0.4液体复苏治疗重症急性胰腺炎患者的临床观察(2)

http://www.100md.com 2008年6月15日 《现代医药卫生》 2008年第12期

     [3] Bockman DE.Microvasculature of the pancreas. Relation to pancre-atitis[J].Int J Pancreatol，1992，12(1):11.

    [4] Tenner S. Initial management ofacutepancreatitis：criticalissues during the first 72 hours[J].Am J Gastroenterol，2004，99(12):2489.

    [5] Clancy TE，Benoit EP，Asbley SW.Current management of acute pan-creatitis[J].J Gastrointest Surg，2005，9(3):440.

    [6] Klar E，Foitzik T，Buhr H，et al.Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Clinical practicability of an experimental concept[J].Ann Surg，1993，217(4):369.

    [7] Deitch EA，Goodman ER. Prevention of multiple organ failure[J].Surg Clin North Am，1999，79(6)：1471.

    [8] Entholzner EK，Miklke LL，Calatzis AN，et al. Coagulation effectsof a recently developed hydroxyethyl starch(HES 130/0.4) compared to hydroxyethyl starches with highermolecular weight[J].Acta Anaes-thesiol Scand，2000，44：1116.

    [9] Jungheinrich C，Sauermann W，Bepperling Vogt NH.Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4(6%) with an optimised in vivo molecular weight in or-thopaedic surgery：a randomised，double-blind study[J]. Drugs R D，2004，5(1):1.

    收稿日期：2008-02-19(高金亭　齐　柯　王甫誉　程新生　郑永彬　缪丁丁)

上一页 第 1 2 页

    百拇医药网 http://www.100md.com/html/paper/1009-5519/2008/12/07-1.htm